Stay updated on Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial
Sign up to get notified when there's something new on the Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial page.

Latest updates to the Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial page
- CheckyesterdayChange DetectedThe TIMELESS study record is now available, detailing a Phase 3 trial of tenecteplase versus placebo for late-window ischemic stroke, its eligibility requirements, study design, and measured outcomes. The record also includes locations, publication references, and study documents.SummaryDifference93%

- Check8 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide banner announces NIH’s terminology transition, stating that “Super Intelligence” is replacing “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe TIMELESS study page now shows a 403 Forbidden error, replacing the usual study details with a generic error screen. Access to the study record and its documents appears blocked, indicating an access issue rather than a content update.SummaryDifference18%

Stay in the know with updates to Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tenecteplase in Stroke Patients 4.5-24 Hours Clinical Trial page.